Yahoo
ASX - Delayed Quote AUD

Atomo Diagnostics Limited (AT1.AX)

0.0140 -0.0010 (-6.67%)
At close: October 30 at 4:10:12 PM GMT+11
AT1.AX Q1 2027 earnings call
November 3, 2026 at 2 PM GMT+11
Chart Range Bar
Loading chart for AT1.AX
  • Previous Close 0.0150
  • Open 0.0150
  • Bid 0.0140 x --
  • Ask 0.0150 x --
  • Day's Range 0.0140 - 0.0150
  • 52 Week Range 0.0140 - 0.0480
  • Volume 7,899,350
  • Avg. Volume 725,841
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-testing programs; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

atomodiagnostics.com

--

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

AT1.AX
61.11%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

AT1.AX
48.15%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

AT1.AX
33.33%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

AT1.AX
95.17%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -65.87%

  • Return on Assets (ttm)

    -31.24%

  • Return on Equity (ttm)

    -47.86%

  • Revenue (ttm)

    5.33M

  • Net Income Avi to Common (ttm)

    -3.51M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.71M

  • Total Debt/Equity (mrq)

    4.84%

  • Levered Free Cash Flow (ttm)

    -2.78M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: